- ASSOCIATE PROFESSOR | Ophthalmology
- Hospital Affiliation
- The Mount Sinai Hospital
- Sinai Doctors 212-731-3355212-731-3355
Over the last 20 years Dr. Eichenbaum has had extensive experience in treating complex problems involving:
- Uveitis, systemic illness and glaucoma;
- Orbital and central nervous system tumors in relationship to the eye, the sinus and the face;
- Difficult to fit contact lens issues, high astigmatism;
- Chronic recurrent dry eye, corneal, inflammatory, infection, and refraction problems;
- Ocular toxicology problems particularly related to the retina and cornea;
- Geriatric eye problems involving cataract, retina, macula, and low vision.
MD, Yale University School of Medicine
Clinical Elective Course, National Institutes of Health
MPH, Columbia University
Internship, Internal Medicine
Washington Hospital Center
Bellevue Hospital Center
Fellowship, Ophthalmic Plastic Surgery
Mount Sinai Hospital
- A Zebrafish Model of Retinal Degeneration Examining: genetics, aging, environment, oxidative stress, protein misfolding, inflammation, and hypoxia.
- Epidemiology of Vision Loss in Geriatric Populations
- Toxicology of Lead and heavy metals in the retina and brain
- Stroke mechanisms in the eye and brain
Eichenbaum JW. Geriatric vision loss due to cataracts, macular degeneration, and glaucoma. The Mount Sinai journal of medicine, New York 2012; 79(2): 276-294.
Eichenbaum JW, Cinaroglu A, Eichenbaum KD, Sadler KC. A zebrafish retinal graded photochemical stress model. Journal of pharmacological and toxicological methods 2009; 59(3): 121-127.
Eichenbaum KD, Mezei M, Eichenbaum JW. Comparing Dynamic Contour Tonometry to Goldman & Hand Held Tonometry in normal Ocular Hypertension & Glaucoma Patients. Annals of Ophthalmology 2007; 39(1): 41-49.
Pevsner PH, Eichenbaum JW, Miller DC, Pivawer G, Eichenbaum KD, Stern A, Zakian KL, Kouther JA. A Photothrombotic Model of Small Early Ischemic Infarcts in the Rat Brain With Histologic and MRI Correlation. Journal of Pharmacological and Toxicological Methods 2001; 45: 227-233.
Eichenbaum JW, Swerdlow F. Pneumocystis carinii pneumonia after reducing prednisone dosage in temporal arteritis. Annals of Ophthalmology and Glaucoma 1999 Jan/Feb; 31(1): 36-38.
[Cataracts] Trudo EW, Stark WJ, [Glaucoma] Podolsky M, [Macular Degeneration] Starr CE, Guyer DR, Yanuzzi LA, [Low Vision] Faye E, [Symposium Coordinator] Eichenbaum JW. A four article symposium on Failing Vision. Postgraduate Medicine 1998 May; 103(5): 113-178.
Weber CM, Eichenbaum JW. Editor Symposium: Acute Red Eye, Differentiating Viral Conjunctivitis from other Less Common Causes. Postgraduate Medicine 1997 May; 101(5): 185-196.
Eichenbaum JW, Burton W, Eichenbaum G, Mulvihill M. The prevalence of eye disease in two NYC nursing homes. Archives of Gerontology and Geriatrics 1999; 28: 191-204.
Eichenbaum JW, editor. Treatment of Retinopathy of Prematurity. 1990, Mosby Year Book, Inc.;.
Eichenbaum JW, Friedman AH, Mamelok AE. A Clinical and Histopathological Review of Intermediate Uveitis (. Bulletin of the New York Academy of Medicine 1998 March; 64(2).
Eichenbaum JW. Trends in Cataract Surgery. Bulletin of the New York Academy of Medicine 1992 July; 68(3): 367-389.
Eichenbaum JW, Feldstein M, Podos SM. Corneal Ulcers in Extended Wear Aphakic Soft Contact Lenses. British Journal of Ophthalmology 1982; 66: 663-666.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Eichenbaum did not report having any of the following types of financial relationships with industry during 2017 and/or 2018: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.